Literature DB >> 28610583

Erratum to: Similar cardiometabolic effects of high- and moderate-intensity training among apparently healthy inactive adults: a randomized clinical trial.

Robinson Ramírez-Vélez1, Alejandra Tordecilla-Sanders2, Luis Andrés Téllez-T2, Diana Camelo-Prieto3, Paula Andrea Hernández-Quiñonez2, Jorge Enrique Correa-Bautista2, Antonio Garcia-Hermoso4, Rodrigo Ramirez-Campillo5,6,7, Mikel Izquierdo8.   

Abstract

Entities:  

Year:  2017        PMID: 28610583      PMCID: PMC5470229          DOI: 10.1186/s12967-017-1238-0

Source DB:  PubMed          Journal:  J Transl Med        ISSN: 1479-5876            Impact factor:   5.531


× No keyword cloud information.

Erratum to: J Transl Med (2017) 15:118 DOI 10.1186/s12967-017-1216-6

In the original version of this article [1], published on 30 May 2017, we noticed an error in Table 2. The lean mass (kg) and fat mass (%) corrected table is included in this erratum.
Table 2

Lean mass (kg) and fat mass (%)

GroupsFrom baseline to 12-week, mean (95% CI)MCT effectp value (ES)HIT effectp value (ES)Time × group p value
BaselineFollow-upWhiting-group changedBetween-group difference in change
MCT (n = 9)HIT (n = 11)MCT (n = 9)HIT (n = 11)MCT (n = 9)HIT (n = 11)
Lean mass (kg)49.7 (9.3)44.9 (5.8)49.4 (8.3)45.9 (5.9)−0.3 (1.2)1.1 (1.2)−1.4 (−2.5 to −0.2)0.237 (0.01)0.007 (0.10)0.156
Body fat (%)27.4 (7.3)31.3 (12.2)27.4 (6.6)30.1 (11.5)0.0 (0.9)−1.2 (1.5)1.2 (0.0 to 2.4)0.500 (0.03)0.014 (0.26)0.026
Lean mass (kg) and fat mass (%) These changes have no material impact on the conclusions of our paper. We apologize for any inconvenience caused to our readers.
  1 in total

1.  Similar cardiometabolic effects of high- and moderate-intensity training among apparently healthy inactive adults: a randomized clinical trial.

Authors:  Robinson Ramírez-Vélez; Alejandra Tordecilla-Sanders; Luis Andrés Téllez-T; Diana Camelo-Prieto; Paula Andrea Hernández-Quiñonez; Jorge Enrique Correa-Bautista; Antonio Garcia-Hermoso; Rodrigo Ramirez-Campillo; Mikel Izquierdo
Journal:  J Transl Med       Date:  2017-05-30       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.